SCHEMBL20867141

SCHEMBL20867141

CCOC(=O)/C(=C/NC1CCC1)C(=N)N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
CYP2D6 P10635 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 2/20 0.37
GLO1 Q04760 1/20 0.37
DHODH Q02127 3/20 0.35
THRB P10828 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 3/20 0.34
GAA P10253 3/20 0.34
TDP1 Q9NUW8 1/20 0.34
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10375705 0.81 CYP2D6 (0.53) ALDH1A1CYP2D6SMN1; SMN2NPSR1GLO1
SCHEMBL24612153 0.81 ADH1B (0.33)
SCHEMBL21863420 0.81 GLO1 (0.43) ALDH1A1CYP2D6SMN1; SMN2NPSR1GLO1
SCHEMBL28118734 0.79 CYP2D6 (0.46) ALDH1A1CYP2D6SMN1; SMN2NPSR1GLO1
SCHEMBL20867083 0.79 CYP2D6 (0.54) ALDH1A1CYP2D6SMN1; SMN2NPSR1GLO1
SCHEMBL20866978 0.77 ALDH1A1 (0.44) ALDH1A1NPSR1THRBATML3MBTL1
SCHEMBL20867250 0.77 ALDH1A1 (0.46) ALDH1A1CYP2D6SMN1; SMN2NPSR1GLO1
SCHEMBL24612160 0.77 ADH1B (0.38) SMN1; SMN2GAANPC1
SCHEMBL21024972 0.77 CYP2D6 (0.47) ALDH1A1CYP2D6SMN1; SMN2NPSR1GLO1
SCHEMBL20867220 0.76 CYP2D6 (0.44) ALDH1A1CYP2D6SMN1; SMN2NPSR1GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 WO disclosed